Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Medical uses  





2 Contraindications  





3 Adverse effects and toxicity  





4 Interactions  





5 Pharmacology  



5.1  Mechanism of action  





5.2  Pharmacokinetics  







6 History  





7 Use as a weapon  



7.1  In fiction  







8 Research  





9 References  





10 Further reading  





11 External links  














Digitoxin






العربية
تۆرکجه
Cymraeg
Dansk
Deutsch
Español
Esperanto
فارسی
Français
Italiano
Македонски
Bahasa Melayu
Nederlands

Polski
Português
Română
Русский
Slovenščina
Српски / srpski
Srpskohrvatski / српскохрватски
Suomi

Українська
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Digitoxin

Clinical data

Trade names

Digalen, Digitaline, Digitmerck, others

Routes of
administration

By mouth, Intravenous injection

ATC code

Legal status

Legal status

  • In general: ℞ (Prescription only)

Pharmacokinetic data

Bioavailability

98–100% (oral)

Protein binding

90–97%

Metabolism

Liver (CYP3A4)

Elimination half-life

7–8 days

Excretion

60% via urine, 40% via faeces

Identifiers

  • (3β,5β)-3-[(O-2,6-dideoxy-
    β-D-ribo-hexapyranosyl-(1->4)-
    2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-
    14-hydroxycard-20(22)-enolide

CAS Number

PubChem CID

IUPHAR/BPS

DrugBank

ChemSpider

UNII

KEGG

ChEBI

ChEMBL

CompTox Dashboard (EPA)

ECHA InfoCard

100.000.691 Edit this at Wikidata

Chemical and physical data

Formula

C41H64O13

Molar mass

764.950 g·mol−1

3D model (JSmol)

  • O=C\1OC/C(=C/1)[C@H]2CC[C@@]8(O)[C@]2(C)CC[C@H]7[C@H]8CC[C@H]6[C@]7(C)CC[C@H](O[C@@H]5O[C@H](C)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@@H]3O[C@@H]([C@@H](O)[C@@H](O)C3)C)[C@@H](O)C4)C)[C@@H](O)C5)C6

  • InChI=1S/C41H64O13/c1-20-36(46)29(42)16-34(49-20)53-38-22(3)51-35(18-31(38)44)54-37-21(2)50-33(17-30(37)43)52-25-8-11-39(4)24(15-25)6-7-28-27(39)9-12-40(5)26(10-13-41(28,40)47)23-14-32(45)48-19-23/h14,20-22,24-31,33-38,42-44,46-47H,6-13,15-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27+,28-,29+,30+,31+,33+,34+,35+,36-,37-,38-,39+,40-,41+/m1/s1 ☒N

  • Key:WDJUZGPOPHTGOT-XUDUSOBPSA-N ☒N

  •  ☒NcheckY (what is this?)  (verify)

    Digitoxin is a cardiac glycoside used for the treatment of heart failure and certain kinds of heart arrhythmia. It is a phytosteroid and is similar in structure and effects to digoxin, though the effects are longer-lasting. Unlike digoxin, which is eliminated from the body via the kidneys, it is eliminated via the liver, and so can be used in patients with poor or erratic kidney function. While several controlled trials have shown digoxin to be effective in a proportion of patients treated for heart failure, the evidence base for digitoxin is not as strong, although it is presumed to be similarly effective.[1]

    Medical uses[edit]

    Digitoxin is used for the treatment of heart failure, especially in people with impaired kidney function. It is also used to treat certain kinds of heart arrhythmia, such as atrial fibrillation.[2][3]

    Contraindications[edit]

    Contraindications include[3]

    Adverse effects and toxicity[edit]

    Digitoxin exhibits similar toxic effects to digoxin, namely: anorexia, nausea, vomiting, diarrhea, confusion, visual disturbances, and cardiac arrhythmias. Antidigoxin antibody fragments, the specific treatment for digoxin poisoning, are also effective in serious digitoxin toxicity.[4]

    Interactions[edit]

    Drugs that can increase digitoxin toxicity include:[3]

    Drugs that can decrease the effectivity of digitoxin include:[3]

    Pharmacology[edit]

    Mechanism of action[edit]

    Digitoxin inhibits the sodium-potassium ATPase in heart muscle cells, resulting in increased force of contractions (positive inotropic), reduced speed of electric conduction (negative dromotropic), increased excitability (positive bathmotropic), and reduced frequency of heartbeat (negative chronotropic).[3]

    Pharmacokinetics[edit]

    The drug is almost completely absorbed from the gut. When in the bloodstream, 90 to 97% are bound to plasma proteins. Digitoxin undergoes enterohepatic circulation. It is metabolized in part by CYP3A4; metabolites include digitoxigenin, digoxin (>2%), and conjugate esters. In healthy people, 60% are eliminated via the kidneys and 40% via the faeces. In people with impaired kidney function, elimination via the faeces is increased. The biological half-life is 7 to 8 days except when kidney and liver functions are impaired, in which case it is usually longer.[3][5]

    History[edit]

    The first description of the use of foxglove dates back to 1775.[6] For quite some time, the active compound was not isolated. Oswald Schmiedeberg was able to obtain a pure sample in 1875. The modern therapeutic use of this molecule was made possible by the works of the pharmacist and the French chemist Claude-Adolphe Nativelle (1812–1889). The first structural analysis was done by Adolf Otto Reinhold Windaus in 1925, but the full structure with an exact determination of the sugar groups was not accomplished until 1962.[7][8]

    Use as a weapon[edit]

    Marie Alexandrine Becker, a Belgian serial killer, was sentenced to death for poisoning eleven people with digitoxin.[citation needed]

    In fiction[edit]

    Digitoxin is used as a poison or murder weapon in:

    InThe Decemberists's song, "The Rake's Song" on The Hazards of Love album, the narrator murders his daughter by feeding her foxglove.

    Research[edit]

    Digitoxin and related cardenolides display anticancer activity against a range of human cancer cell lines in vitro but the clinical use of digitoxin to treat cancer has been restricted by its narrow therapeutic index.[9][10] Digitoxin glycorandomization led to the discovery of novel digitoxigenin neoglycosides which displayed improved anticancer potency and reduced inotropic activity (the perceived mechanism of general toxicity).[11]

    References[edit]

    1. ^ Belz GG, Breithaupt-Grögler K, Osowski U (2001). "Treatment of congestive heart failure--current status of use of digitoxin". European Journal of Clinical Investigation. 31 (Suppl 2): 10–7. doi:10.1046/j.1365-2362.2001.0310s2010.x. PMID 11525233. Archived from the original on 2013-01-05.
  • ^ Erland Erdmann, ed. (2013). Therapie mit Herzglykosiden (in German). Springer. p. 43. ISBN 978-3-642-69046-4.
  • ^ a b c d e f Haberfeld H, ed. (2021). Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. Digimerck 0,07 mg - Tabletten.
  • ^ Kurowski V, Iven H, Djonlagic H (1992). "Treatment of a patient with severe digitoxin intoxication by Fab fragments of anti-digitalis antibodies". Intensive Care Medicine. 18 (7): 439–42. doi:10.1007/BF01694351. PMID 1469187. S2CID 2324996.
  • ^ "mediQ: Digitoxin". Retrieved 2021-09-14.
  • ^ Withering W (1785). An Account of the Foxglove and Some of its Medical Uses: With Practical Remarks on Dropsy and other Diseases. Classics of Medicine Library.
  • ^ Diefenbach WC, Meneely JK (May 1949). "Digitoxin; a critical review". The Yale Journal of Biology and Medicine. 21 (5): 421–31. PMC 2598854. PMID 18127991.
  • ^ Sneader W (2005). Drug discovery: A history. Wiley. p. 107. ISBN 978-0-471-89980-8.
  • ^ Menger L, Vacchelli E, Kepp O, Eggermont A, Tartour E, Zitvogel L, et al. (February 2013). "Trial watch: Cardiac glycosides and cancer therapy". Oncoimmunology. 2 (2): e23082. doi:10.4161/onci.23082. PMC 3601180. PMID 23525565.
  • ^ Elbaz HA, Stueckle TA, Tse W, Rojanasakul Y, Dinu CZ (April 2012). "Digitoxin and its analogs as novel cancer therapeutics". Experimental Hematology & Oncology. 1 (1): 4. doi:10.1186/2162-3619-1-4. PMC 3506989. PMID 23210930.
  • ^ Langenhan JM, Peters NR, Guzei IA, Hoffmann FM, Thorson JS (August 2005). "Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization". Proceedings of the National Academy of Sciences of the United States of America. 102 (35): 12305–10. Bibcode:2005PNAS..10212305L. doi:10.1073/pnas.0503270102. PMC 1194917. PMID 16105948.
  • Further reading[edit]

  • Hippius M, Humaid B, Sicker T, Hoffmann A, Göttler M, Hasford J (August 2001). "Adverse drug reaction monitoring--digitoxin overdosage in the elderly". International Journal of Clinical Pharmacology and Therapeutics. 39 (8): 336–43. doi:10.5414/cpp39336. PMID 11515708.
  • Haux J, Klepp O, Spigset O, Tretli S (2001). "Digitoxin medication and cancer; case control and internal dose-response studies". BMC Cancer. 1: 11. doi:10.1186/1471-2407-1-11. PMC 48150. PMID 11532201.
  • Srivastava M, Eidelman O, Zhang J, Paweletz C, Caohuy H, Yang Q, et al. (May 2004). "Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells". Proceedings of the National Academy of Sciences of the United States of America. 101 (20): 7693–8. Bibcode:2004PNAS..101.7693S. doi:10.1073/pnas.0402030101. PMC 419668. PMID 15136726.
  • External links[edit]

    Media related to Digitoxin at Wikimedia Commons

    Bond

  • N-glycosidic bond
  • S-glycosidic bond
  • C-glycosidic bond
  • Geometry

  • β-Glycoside
  • 1,4-Glycoside
  • 1,6-Glycoside
  • Glycone

  • Galactoside
  • Glucoside
  • Glucuronide
  • Rhamnoside
  • Riboside
  • Aglycone

  • Cardiac glycoside
  • Cyanogenic glycoside
  • Glycosylamine
  • Phenolic glycoside
  • Saponin
  • Steviol glycoside
  • Thioglycoside
  • Bufadienolides

    Bufo

  • Bufotalin
  • Cinobufagin
  • Marinobufagin
  • Scilla

  • Scilliroside
  • Kalanchoe

    Cardenolides

    Digitalis

  • Acetyldigoxin
  • Digitoxin#
  • Digoxin#
  • Lanatoside C
  • Deslanoside
  • Metildigoxin
  • Gitoformate
  • Strophanthus

  • k-Strophanthin
  • Cymarin
  • Thevetia

  • Withdrawn from market
  • Clinical trials:
  • §Never to phase III
  • ERTooltip Estrogen receptor

    Agonists

  • 2-Hydroxyestrone
  • 3-Methyl-19-methyleneandrosta-3,5-dien-17β-ol
  • 3α-Androstanediol
  • 3α,5α-Dihydrolevonorgestrel
  • 3β,5α-Dihydrolevonorgestrel
  • 3α-Hydroxytibolone
  • 3β-Hydroxytibolone
  • 3β-Androstanediol
  • 4-Androstenediol
  • 4-Androstenedione
  • 4-Fluoroestradiol
  • 4-Hydroxyestradiol
  • 4-Hydroxyestrone
  • 4-Methoxyestradiol
  • 4-Methoxyestrone
  • 5-Androstenediol
  • 7-Oxo-DHEA
  • 7α-Hydroxy-DHEA
  • 7α-Methylestradiol
  • 7β-Hydroxyepiandrosterone
  • 8,9-Dehydroestradiol
  • 8,9-Dehydroestrone
  • 8β-VE2
  • 10β,17β-Dihydroxyestra-1,4-dien-3-one (DHED)
  • 11β-Chloromethylestradiol
  • 11β-Methoxyestradiol
  • 15α-Hydroxyestradiol
  • 16-Ketoestradiol
  • 16-Ketoestrone
  • 16α-Fluoroestradiol
  • 16α-Hydroxy-DHEA
  • 16α-Hydroxyestrone
  • 16α-Iodoestradiol
  • 16α-LE2
  • 16β-Hydroxyestrone
  • 16β,17α-Epiestriol (16β-hydroxy-17α-estradiol)
  • 17α-Estradiol (alfatradiol)
  • 17α-Dihydroequilenin
  • 17α-Dihydroequilin
  • 17α-Epiestriol (16α-hydroxy-17α-estradiol)
  • 17α-Ethynyl-3α-androstanediol
  • 17α-Ethynyl-3β-androstanediol
  • 17β-Dihydroequilenin
  • 17β-Dihydroequilin
  • 17β-Methyl-17α-dihydroequilenin
  • Abiraterone
  • Abiraterone acetate
  • Alestramustine
  • Almestrone
  • Anabolic steroids (e.g., testosterone and esters, methyltestosterone, metandienone (methandrostenolone), nandrolone and esters, many others; via estrogenic metabolites)
  • Atrimustine
  • Bolandiol
  • Bolandiol dipropionate
  • Butolame
  • Clomestrone
  • Cloxestradiol
  • Conjugated estriol
  • Conjugated estrogens
  • Cyclodiol
  • Cyclotriol
  • DHEA
  • DHEA-S
  • ent-Estradiol
  • Epiestriol (16β-epiestriol, 16β-hydroxy-17β-estradiol)
  • Epimestrol
  • Equilenin
  • Equilin
  • ERA-63 (ORG-37663)
  • Esterified estrogens
  • Estetrol
  • Estradiol
  • Estramustine
  • Estramustine phosphate
  • Estrapronicate
  • Estrazinol
  • Estriol
  • Estrofurate
  • Estrogenic substances
  • Estromustine
  • Estrone
  • Etamestrol (eptamestrol)
  • Ethinylandrostenediol
  • Ethinylestradiol
  • Ethinylestriol
  • Ethylestradiol
  • Etynodiol
  • Etynodiol diacetate
  • Hexolame
  • Hippulin
  • Hydroxyestrone diacetate
  • Lynestrenol
  • Lynestrenol phenylpropionate
  • Mestranol
  • Methylestradiol
  • Moxestrol
  • Mytatrienediol
  • Nilestriol
  • Norethisterone
  • Noretynodrel
  • Orestrate
  • Pentolame
  • Prodiame
  • Prolame
  • Promestriene
  • RU-16117
  • Quinestradol
  • Quinestrol
  • Tibolone
  • Mixed
    (SERMsTooltip Selective estrogen receptor modulators)

  • 2-Phenylbenzothiophene
  • 4'-Hydroxynorendoxifen
  • 27-Hydroxycholesterol
  • Acefluranol
  • Acolbifene
  • Afimoxifene
  • Anordiol
  • Anordrin
  • Arzoxifene
  • Bazedoxifene
  • Brilanestrant
  • Broparestrol
  • Camizestrant
  • Chlorotrianisene
  • Clomifene
  • Clomifenoxide
  • CN-55945-27
  • Cyclofenil
  • D-15413
  • Desmethylchlorotrianisene
  • Droloxifene
  • Enclomifene
  • Endoxifen
  • Etacstil (GW-5638, DPC-974)
  • Ethamoxytriphetol (MER-25)
  • Femarelle
  • Fispemifene
  • GW-7604
  • ICI-55548
  • Idoxifene
  • Lasofoxifene
  • Levormeloxifene
  • LN-1643
  • LN-2299
  • LY-117018
  • Menerba
  • Miproxifene
  • Miproxifene phosphate
  • MRL-37
  • Nafoxidine
  • Nitromifene
  • NNC 45-0095
  • NNC 45-0320
  • NNC 45-0781
  • NNC 45-1506
  • Ormeloxifene
  • Ospemifene
  • Panomifene
  • Pipendoxifene
  • Promensil
  • Raloxifene
  • Rimostil (P-081)
  • Spironolactone
  • SS1010
  • Tamoxifen
  • TAS-108 (SR-16234)
  • Toremifene
  • Trioxifene
  • TZE-5323
  • U-11555A
  • U-11634
  • Y-134
  • Zindoxifene
  • Zuclomifene
  • Antagonists

  • 7β-Hydroxy-DHEA
  • Chloroindazole
  • Cytestrol acetate
  • EM-800 (SCH-57050)
  • Epitiostanol
  • ERA-90
  • ERB-88
  • Fulvestrant (ICI-182780)
  • Glyceollins (I, II, III, IV)
  • ICI-164384
  • MDL-101906
  • Mepitiostane
  • Methylepitiostanol
  • Methylpiperidinopyrazole
  • MIBE
  • Oxabicycloheptene sulfonate
  • Phenytoin
  • PHTPP
  • Prochloraz
  • RU-39411
  • RU-58668
  • SS1020
  • TAS-108 (SR-16234)
  • ZB716
  • ZK-164015
  • ZK-191703
  • GPERTooltip G protein-coupled estrogen receptor

    Agonists

  • 7β-Hydroxyepiandrosterone
  • Afimoxifene (4-hydroxytamoxifen)
  • Aldosterone
  • Atrazine
  • Bisphenol A
  • Daidzein
  • DDT (p,p'-DDT, o',p'-DDE)
  • Diarylpropionitrile
  • Equol
  • Estradiol
  • Ethinylestradiol
  • Fulvestrant (ICI-182780)
  • G-1
  • Genistein
  • GPER-L1
  • GPER-L2
  • Hydroxytyrosol
  • Kepone
  • Niacin
  • Niacinamide
  • Nonylphenol
  • Oleuropein
  • PCBs (2,2',5'-PCB-4-OH)
  • Propylpyrazoletriol
  • Quercetin
  • Raloxifene
  • Resveratrol
  • STX
  • Tamoxifen
  • Tectoridin
  • Antagonists

  • Estriol
  • G-15
  • G-36
  • MIBE
  • Unknown

  • Zearalenone
  • See also
    Receptor/signaling modulators
    Estrogens and antiestrogens
    Androgen receptor modulators
    Progesterone receptor modulators
    List of estrogens


    Retrieved from "https://en.wikipedia.org/w/index.php?title=Digitoxin&oldid=1223943353"

    Categories: 
    Cardenolides
    Estrogens
    Drugs developed by Merck
    Hidden categories: 
    CS1 German-language sources (de)
    Articles with short description
    Short description matches Wikidata
    Drugs with non-standard legal status
    Articles with changed DrugBank identifier
    Articles with changed ChemSpider identifier
    Articles with changed KEGG identifier
    Articles with changed EBI identifier
    ECHA InfoCard ID from Wikidata
    Articles with changed InChI identifier
    Drugboxes which contain changes to verified fields
    Drugboxes which contain changes to watched fields
    All articles with unsourced statements
    Articles with unsourced statements from September 2021
    Commons category link from Wikidata
    Pages with login required references or sources
    Pages containing links to subscription-only content
     



    This page was last edited on 15 May 2024, at 09:05 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki